Aquestive Therapeutics, Inc. AQST Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s shares (diluted)?
- Aquestive Therapeutics, Inc. (AQST) reported shares (diluted) of 122.6M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Aquestive Therapeutics, Inc.'s shares (diluted) increased by 28.4% year-over-year, from 95.5M to 122.6M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s shares (diluted) has grown at a 28.8% compound annual growth rate (CAGR), from 149.9M to 412.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.